-
Addressing Key Client Objectives
Strategic
M&A
Fund Raising and
Secondary Sales
Balance Sheet
Management
Capital
Raising
Activism
Response
-
Featured Transactions See All
-
Advising
on its $7.2 billion acquisition
of GW pharmaceuticals -
~$403 Million
Convertible Notes Offering
Sole Bookrunner
January 2021 -
Active Bookrunner
$575 Million
Convertible Note Offering -
Advising
on its pending $39 billion acquisition of
Alexion -
Advising
on its pending $11.6 billion acquisition of
BBVA USA Bancshares -
Sole Bookrunner
$414 Million
CAPS ™ Initial Public Offering -
Advising
on its pending $11.9 billion sale to
Liberty Broadband -
Advising
on its pending ~ $7.5 billion merger with
Just Eat Takeway -
Active Bookrunner
$3.5 Billion
Follow-on Offering &
5.0% Mandatory Convertible
Preferred -
Advising
on the pending ~$45 billion merger of its Nutrition &
Biosciences business via a Reverse Morris Trust with IFF
-
Advised
on its approximately $60 billion sale to
Occidental Petroleum
-
-
Evercore By the Numbers
-
Why Evercore?
-
Research from Evercore ISI
-
Wealth Management
